Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Supply chain

Treasury promises £434m to support medicines supply chain after no-deal Brexit

The UK chancellor has committed to spending an extra £434m on ensuring the continued supply of medicines in the event of a no-deal Brexit.

The money forms part of a larger announcement of funding worth £2.1bn for no-deal Brexit preparations across several government departments.

In the Treasury statement published on 1 August 2019, Sajid Javid — who was appointed as UK chancellor on 24 July 2019 by the new prime minister Boris Johnson — said the £434m will be “made available to help ensure continuity of vital medicines and medical products, including through freight capacity, warehousing and stockpiling”.

The Department of Health and Social Care (DHSC) was previously allotted £50m for no-deal Brexit preparations in 2019/2020, having set aside £3m to transport short-life medicines and medical devices and spent an undisclosed amount of money in the “low tens of millions” of pounds on refrigerated storage.

However, the Treasury has confirmed to The Pharmaceutical Journal that the latest tranche of funding will be entirely new money.

Plans to maintain the drugs supply in the event of a no-deal Brexit were put on hold after two Brexit extensions were agreed between the UK government and the EU, with the UK now expected to leave the EU on 31 October 2019.

Following the second extension in April 2019, the DHSC wrote to pharmaceutical firms asking them to keep their previously-agreed six-week rolling stockpile of drugs “in place but on hold” until further notice.

Then in June 2019, Steve Oldfield, chief commercial officer at the DHSC, wrote to drugs firms and the wider healthcare sector setting out further no-deal Brexit planning and warning that there would be “significant disruption” for six months in the event of the UK leaving the UK with no agreement in place.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2019.20206888

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • BNF and BNF for Children

    BNF and BNF for Children

    Now available as a 1 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £138.50Buy now
  • BNF and BNF for Children

    BNF and BNF for Children

    Now available as a 2 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £262.50Buy now
  • Pharmaceutical Toxicology

    Pharmaceutical Toxicology

    Explains the methodology and requirements of pre-clinical safety assessments of new medicines. Includes registration requirements and pharmacovigilance.

    £40.00Buy now
  • Strategic Medicines Management

    Strategic Medicines Management

    A practical guide to influencing the availability of medicines, and policies of their use. Focuses on the strategic elements of medicines management.

    £33.00Buy now
  • Introduction to Clinical Pharmaceutics (An)

    Introduction to Clinical Pharmaceutics (An)

    This unique textbook covers the role of basic pharmaceutics in clinical outcomes and in explaining the behaviour of medicines in the body.

    £27.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.